Germany’s Merck KGaA is in advanced talks for a potential acquisition of SpringWorks Therapeutics, a U.S. biopharmaceutical ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET ...

Neuphoria Therapeutics said it expects to receive a milestone payment from Merck for the second clinical trial phase of its Alzheimer's disease dementia treatment.

SpringWorks Therapeutics shares rose 36% after Reuters reported Germany's Merck KGaA is in advanced talks to buy the company. Shares were trading around $54.66. The stock is up 16% over the last year ...

The rumour that Merck & Co is preparing to make a sizeable offer to buy cancer specialist Seagen won't go away. The latest report - in the Wall Street Journal – says that "advanced talks" are ...

Major stock indexes closed higher on Friday, driven by corporate earnings reports from tech firms like Alphabet and Amazon.

people familiar with the matter told The Wall Street Journal’s Liz Essley Whyte and Betsy McKay. Under the order, the Food and Drug Administration, Centers for Disease Control and Prevention and ...

Catch up on the top industries and stocks that were impacted, or were predicted to be impacted, by the comments, actions and policies of ...

British defence group Babcock on Thursday hiked its revenue expectations for the year to around 4.9 billion pounds ($6.11 billion), on the back of strength in its nuclear and marine segments.

Stocks remain jittery on a mix of inflation worry coupled with concern over how Trump’s plan for tariffs could affect the U.S. economy ...